Sep 13, 2023
Maria Pereira Co-Founder and Chief Innovation Officer at TISSIUM, discusses her journey to develop a biocompatible, biodegradable polymer to enable atraumatic surgical procedures for tissue repair. This new polymer technology can be used as a sealant and adhesive to replace the use of tacks and sutures to repair blood vessels, nerve damage, and meshes without the use of any penetrating or traumatic fixation.
Maria explains, "At TISSIUM, we are developing a new core technology, a new material that can be used for a traumatic tissue repair. We are leveraging a material that has been originally developed at MIT. One of the features of this material is that it can be used as a sealant or an adhesive, or even as a resin for 3D printing and drug delivery. And we can apply this material in surgery to enable surgical procedures in an atraumatic way."
"Currently, we're developing products across three main domains, including cardiovascular, where we use the material as a sealant to stop blood leaks during cardiovascular surgery. We're also operating in the space of peripheral nerve repair, where we are developing an atraumatic solution where we can basically bring nerves together without the use of any sutures or other traumatic technologies. The third space where we are currently operating is in hernia repair, where we are using our materials as an adhesive to fix meshes to the abdominal wall, and therefore avoiding the use of tacks that can induce trauma and pain."
#TISSIUM #Medtech #MedicalInnovation #TissueRepair #Sealant #Adhesive
